TY - JOUR
T1 - Treatment-related leukemia
AU - Coltman, Charles A.
AU - Dahlberg, Steve
PY - 1990/1/4
Y1 - 1990/1/4
N2 - The majority of the published studies addressing the question of treatment-related leukemia used cohort methods of analysis in which the incidence of leukemia was measured among patients treated for primary cancer. Comparisons of the risk of leukemia have been made between patients and age- and sex-matched populations or between subsets of patients treated with different regimens. There may be bias associated with these methods,1 in that patients with Hodgkin's disease, for example, may differ from the “normal” population with respect to the risk of leukemia. The differences could include the more careful follow-up of patients with Hodgkin's disease, or more …
AB - The majority of the published studies addressing the question of treatment-related leukemia used cohort methods of analysis in which the incidence of leukemia was measured among patients treated for primary cancer. Comparisons of the risk of leukemia have been made between patients and age- and sex-matched populations or between subsets of patients treated with different regimens. There may be bias associated with these methods,1 in that patients with Hodgkin's disease, for example, may differ from the “normal” population with respect to the risk of leukemia. The differences could include the more careful follow-up of patients with Hodgkin's disease, or more …
UR - http://www.scopus.com/inward/record.url?scp=0025190954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025190954&partnerID=8YFLogxK
U2 - 10.1056/NEJM199001043220109
DO - 10.1056/NEJM199001043220109
M3 - Editorial
C2 - 2294417
AN - SCOPUS:0025190954
VL - 322
SP - 52
EP - 53
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 1
ER -